- Professor of Medicine
- University of Utah School of Medicine
- Associate Chief of Cardiology
- Director, Cardiovascular Research
- Intermountain Heart Institute
- Intermountain Medical Center
Jeffrey L. Anderson, MD, attended Harvard Medical School, graduating with honors, after receiving his baccalaureate degree magna cum laude in Chemistry at the University of Utah. He completed a post-doctoral fellowship in Cardiology at Stanford University after 2 years as a Staff Associate at the National Institutes of Health. He began academic medicine at the University of Michigan, subsequently joining the faculty at the University of Utah.
Dr. Anderson is board certified in internal medicine, cardiovascular disease, and clinical electrophysiology. He currently serves as Associate Chief of Cardiology, Director of Cardiovascular Research, and Vice-Chair for Medical Research, Department of Medicine, Intermountain Medical Center, and Professor of Internal Medicine, University of Utah School of Medicine. He is a fellow of the American College of Cardiology and the American Heart Association's Clinical Council and Master of the American College of Physicians.
Dr. Anderson has contributed to cardiovascular research over a broad area, including antithrombotic therapy of acute myocardial infarction and unstable angina, primary and secondary prevention of coronary heart disease, antiarrhythmic therapy, trials in congestive heart failure, and, currently, research on genetics, pharmacogenetics, and novel biomarker and imaging indicators for cardiovascular disease and prevention. Dr. Anderson currently chairs the ACC/AHA Task Force on Practice Guidelines, which recently has published new or updated guidelines on ST-elevation myocardial infarction (MI), non-STEMI, stable ischemic heart disease, and cardiovascular prevention (e.g., cholesterol guidelines). He is an author or co-author on more than 680 original or invited publications and 540 abstracts. In addition, Dr. Anderson has served as a reviewer or editorial board member of 15 peer-reviewed journals and online information resources for professionals. He has served on and chaired FDA's advisory committee on cardiorenal drugs and has served on many volunteer leadership positions for ACC/AHA. He maintains a full activity schedule of teaching, administration, and clinical care and research